CMCF02A
CMCF02A is a potent inhibitory peptide of the MAGE-A4 binding axis and can be used in melanoma-related research[1].
Product Specifications
UNSPSC
12352209
Target
Others
Related Pathways
Others
Field of Research
Cancer
Smiles
O=C(C)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N1[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CS2)=O)CC(O)=O)=O)C(C)C)=O)CCC1)=O)CC3=CNC=N3)=O)CC(O)=O)=O)CC4=CC=CC=C4)=O)[C@H](CC)C)=O)CCCNC(N)=N)=O)[C@H](CC)C)=O)CC5=CC=CC=C5)=O)CC6=CC2=C(O)C(O)=C6)=O)CCSC
Molecular Formula
C79H111N19O20S2
Molecular Weight
1710.97
References & Citations
[1]Fleming MC, et al. Tyrosinase-Catalyzed Peptide Macrocyclization for mRNA Display. J Am Chem Soc. 2023 May 17;145 (19) :10445-10450.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
